Skip to main content

Advertisement

Fig. 3 | Clinical Epigenetics

Fig. 3

From: Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

Fig. 3

Pathway analysis of candidate genes significantly altered by TET2-knockout. Selected, significant pathway enrichment annotations from GREAT for genes exhibiting significantly altered expression in both TET2-knockout cell lines and in tumor versus normal samples from the TCGA (binomial p value < 0.05). Bar coloration indicates the number of candidate genes enriched within each pathway

Back to article page